Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1465-1477

  Fragale, Alessandra ^a   Tartaglia, Marco ^a   Bernardini, Silvia ^b   Di Stasi, A M Michela ^a   Di Rocco, Concezio ^b   Velardi, Francesco ^b   Teti, Anna ^c   Battaglia, Piero A ^a   Migliaccio, Silvia ^a,d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d Dipto di Medicina Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR;

ACROCEPHALOSYNDACTYLY; ARTICLE; BONE MINERALIZATION; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CRANIOFACIAL SYNOSTOSIS; ENZYME ACTIVITY; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; MALE; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; SKULL DEVELOPMENT;

EID: 0032934535     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65401-6     Document Type: Article

References (51)

1. Cohen MM Jr: Craniosynostosis: diagnosis, evaluation and management. New York, Raven Press, 1986
2. Di Rocco C, Velardi F: Surgical management of craniosynostosis. Craniosynostosis. Edited by G Galli. Boca Raton, FL, CRC Press, 1984, pp 181-248
3. McKusick VA: Mendelian inheritance in man. Catalogs of Human Genes and Genetic Disorders. Baltimore, Johns Hopkins University Press, 1994
4. Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P: Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet 1996, 63:148-154
5. Wilkie AOM: Genes and mechanisms. Hum Mol Genet 1997, 6:1647-1656
6. Jaye M, Schlessinger J, Dionne CA: Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochem Biophys Acta 1992, 1135:185-190
7. Basilico C, Moscatelli D: The FGF family of growth factors, and oncogenes. Adv Cancer Res 1992, 59:115-165
8. Fernig DJ, Gallager JT: Fibroblast growth factors and their receptor: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 1994, 5:353-377
9. Nakafuku M, Satoh T, Kaziro Y: Differentiation factors, including nerve growth factor, fibroblast growth factor and interleukin-6, induce an accumulation of an active Ras GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 1992, 267:19448-19454
10. Wang JK, Xu H, Li H-C, Goldfarb M: Broadiy expressed SNT-like proteins link FGF receptor stimulation to activators of RAS. Oncogene 1996, 12:721-729
11. Burgess WH, Dionne CA, Kaplow J, Mudd R, Friesel R, Zilberstein A, Schlessinger J, Jaye M: Characterization and cDNA cloning of phospholipase C-γ, a major substrate for heparin growth factor 1 (acidic fibroblast growth factor) activated tyrosme kinase. Mol Cell Biol 1990, 10:4770-4777
12. Neilson KM, Friesel RE: Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 1995, 270:26037-26040
13. Mangasarian K, Li Y, Mansukhani A, Basilico C: Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J Cell Physiol 1997, 172:117-125
14. Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ: Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulphide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 1998, 95:4567-4572
15. Anderson J, Burns HD, Enriquez-Harris P, Wilkie AOM, Heath JK: Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 1998, 7:1475-1483
16. Mundolos S, Olsen BR: Heritable diseases of the skeleton. Part I: molecular insights into skeletal development-transcription factors and signalling pathways. FASEB J 1997, 11:125-132
17. Canalis E: The hormonal and local regulation of bone formation. Endocrin Rev 1983, 4:62-67
18. Hurley MM, Kessler M, Gronowicz G, Raisz LG: The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal ray calvariae. Endocrinology 1992, 130:2675-2682
19. Tang K-S, Capparelli C, Stein JL, Stein GS, Lian JB, Huber AC, Braverman LE, DeVito WJ: Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes. J Cell Biochem 1996, 61:152-166
20. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R: Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997, 138:4456-4462
21. Debiais F, Hott M, Graulet AM, Marie PJ: The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 1998, 13:645-654
22. Iseki S, Wilkie, AOM, Heath JK, Ishimaru T, Eto K, Morris-Kay GM: Fgfr2, and osteopontin domains in the developing skull vault are mutually exclusive, and can be altered by locally applied FGF2. Development 1997, 124:3357-3384
23. Kim H-J, Rice DPC, Kettunen PJ, Thesleff I: FGF-, BMP-, and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis, and calvarial bone development. Development 1998, 125:1241-1251
24. Most D, Levine JP, Chang J, Sung J, McCarthy JG, Schendel SA, Longaker MT: Studies in cranial suture biology: up-regulation of transforming growth factor-β 1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 1998, 101:1431-1440
25. De Pollack C, Renier D, Hott M, Marie PJ: Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Min Res 1996, 11:401-407
26. Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ: Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 1998, 101:1310-1317
27. Cohen MM Jr: Pfeiffer syndrome update, clinical subtypes and guideline for differential diagnosis. Am J Med Genet 1993, 45:300-307
28. Tartaglia M, Valeri S, Velardi F, Di Rocco C, Battaglia PA: Trp290Cys mutation in the exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. Hum Genet 1997, 99:602-606
29. Tartaglia M, Di Rocco C, Lajeunie E, Valeri S, Velardi F, Battaglia PA: Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet 1997, 101:47-50
30. Tartaglia M, Saulle E, Bordoni V, Battaglia PA: Polymorphism at position 882 of the fibroblast growth factor receptor 3 (FGFR3) gene detected by SSCP analysis. Mol Cell Probes 1998, 12:335-337
31. Przylepa KA, Paznekas W, Zhang M, Golabi M, Bias W, Bamshad MJ, Carey JC, Hall BD, Stevenson R, Orlow SJ, Cohen MM Jr, Jabs EW: Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet 1996, 13:492-494
32. Robey Gehron P, Termine JD: Human bone cells in vitro. Calcif Tissue Int 1985, 37:453-460
33. Bills CE, Eisenberg H, Pallante SL: Complexes of organic acids with calcium phosphate: the von Kossa stain as clue to the composition of bone mineral. Johns Hopkins Med J 1971, 128:194-207
34. Fisher LW, Stubb JT 3rd, Young MF: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand (suppl) 1995, 266:61-65
35. Wodgett JR, Hunter T: Immunological evidence for two physiological forms of protein kinase C. Mol Cell Biol 1987, 7:85-96
36. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994, 15:439-461
37. Wergedal JE, Baylink DJ: Characterization of cells isolated from human bone. Proc Soc Exp Biol Med 1984, 176:60-69
38. Migliaccio S, Wetsel WC Fox WM, Washburn TF, Korach KS: Endogenous protein kinase-C activation in osteoblasts-like cells modulates responsiveness to estrogens and estrogen receptor levels. Mol Endocrinol 1993, 7:1133-1143
39. Fedarko NS, Bianco P, Vetter U, Gehron Robey P: Human bone cell enzyme expression and cellular heterogeneity: correlation of alkaline phosphatase enzyme activity with cell cycle. J Cell Physiol 1990, 144:115-121
40. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA: Mineralization and expression of matrix proteins during in vivo bone development. Calcif Tissue Int 1998, 62:74-82
41. Bellows CG, Aubin JE, Heersche JNM: Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 1987, 121:1985-1992
42. Gundle R, Bradley J, Joyner C, Francis M, Beresford J: Bone formation in vivo and in vitro by cultured adult human bone-derived cells. J Bone Min Res 1993, 8:S374
43. Stein GS, Lian JB: Molecular mechanisms mediating proliferation/ differentiation interrelationship during progressive development of the osteoblast phenotype. Endocr Rev 1993, 14:424-442
44. Hug H, Sarre TF: Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993, 291:329-343
45. Jaken S: Protein kinase C isoenzymes and substrates. Curr Biol 1996, 8:168-173
46. Migliaccio S, Bernardini S, Wetsel WC, Korach KS, Faraggiana T, Teti A: Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro. Steroid 1998, 63:352-354
47. Sanders JL, Stern PH: Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts. J Bone Min Res 1996, 11:1862-1872
48. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcom S, Winter RM, Reardon W: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995, 9:165-172
49. Aubin JE, Turksen K, Heersche JNM: Osteoblastic cell lineage. Cellular and Molecular Biology of the Bone. Edited by M Noda. San Diego, Academic Press, 1993, pp 1-45
50. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS: Progressive development of rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990, 143:420-430
51. Stein GS, Lian JB, Van Wijnen AJ, Montecino M: Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996, 76:593-629